During the past decade, IMA Brasil - Instituto de Pesquisa Clínica e Medicina Avançada conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 6 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "IMA Brasil - Instituto de Pesquisa Clínica e Medicina Avançada" #1 sponsor was "Eurofarma Laboratorios S.A." with 5 trials, followed by "Genentech, Inc." with 2 trials sponsored, "Mannkind Corporation" with 2 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "IMA Brasil - Instituto de Pesquisa Clínica e Medicina Avançada" #1 collaborator was "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "IMA Brasil - Instituto de Pesquisa Clínica e Medicina Avançada" are "Asthma" (4 trials), "Arthritis, Rheumatoid" (2 trials), "Rheumatoid Arthritis" (2 trials), "Allergic Rhinitis" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "IMA Brasil - Instituto de Pesquisa Clínica e Medicina Avançada" in a lesser frequency.

Most popular intervention types in "IMA Brasil - Instituto de Pesquisa Clínica e Medicina Avançada" are "Drug" (12 trials). Other intervention types were less common.

The name of intervention was led by "GDC-0853" (2 trials), "Placebo" (2 trials), "Technosphere Insulin" (2 trials), "Active comparator" (1 trials) and "Adalimumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "IMA Brasil - Instituto de Pesquisa Clínica e Medicina Avançada" are 12 trials for "All" genders.

Currently, there are NaN active trials in "IMA Brasil - Instituto de Pesquisa Clínica e Medicina Avançada". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in IMA Brasil - Instituto de Pesquisa Clínica e Medicina Avançada, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in IMA Brasil - Instituto de Pesquisa Clínica e Medicina Avançada, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".